Overview
Krebs Biochemicals & Industries Ltd specializes in manufacturing Active Pharmaceutical Ingredients using a unique fermentation process. It is among a few globally employing this method.
The company is engaged in biotechnology, applying its processes in medicine, agriculture, and industry. This includes contract manufacturing for large multinational companies.
Krebs has increased its production capacity from an initial 60 TPA to 150 TPA, demonstrating significant growth since its commercial operations started in 1994.
In 2003-04, the company also branched into renewable energy by commissioning a 2.5 MW co-generation power plant in Vizag.
- Sector
Pharmaceuticals & Biotechnology
- Industry
Pharmaceuticals
- Market Cap
116 Cr
- Volatility
Low Risk
- P/E Ratio
0.0
- Industry P/E
36.7
- PEG Ratio
—
- P/B Ratio
—
- 52W High
81.80
- 52W Low
38.52
Financial Ratios
Sales CAGR
- 1Y
- -14.10%
- 3Y
- -10.15%
- 5Y
- 5.33%
- 10Y
- 46.31%
Profit CAGR
- 1Y
- -36.54%
- 3Y
- —
- 5Y
- —
- 10Y
- —
ROE
- TTM
- 10.40%
- 3Y
- 19.55%
- 5Y
- 29.88%
- 10Y
- 46.32%
ROCE
- TTM
- -9.06%
- 3Y
- -18.77%
- 5Y
- -22.43%
- 10Y
- -20.27%
Technicals
Oscillators
Neutral
Bearish
5
Neutral
6
Bullish
3
Overall
Bearish
Bearish
29
Neutral
6
Bullish
11
Moving Averages
Bearish
Bearish
24
Neutral
0
Bullish
8
Actions
AI Mode
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Ask AI
